20/09/2025
Diabetes update
Wegovy (semaglutide) continues to transform the management of type 2 diabetes and obesity in 2025, showing powerful benefits for weight loss, improved blood sugar, and heart health. Exploring both the injectable and upcoming oral options, doctors now have more tools to help patients thrive.